Michael W. Dunne's Insider Trades & SAST Disclosures
Michael W. Dunne's most recent trade in Iterum Therapeutics Plc was a trade of 212,494 Subscription Rights (right to buy) done . Disclosure was reported to the exchange on Aug. 6, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Michael W. Dunne.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Iterum Therapeutics Plc | Michael W. Dunne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2024 | 212,494 | 0 | - | - | Subscription Rights (right to buy) | |
| Iterum Therapeutics Plc | Michael W. Dunne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2024 | 106,247 | 220,001 (1%) | 0% | - | Ordinary Shares | |
| Iterum Therapeutics Plc | Michael W. Dunne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2024 | 106,247 | 106,247 | - | - | Warrants (right to buy) | |
| Iterum Therapeutics Plc | Michael W. Dunne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2024 | 106,247 | 106,247 | - | - | Warrants (right to buy) | |
| Iterum Therapeutics Plc | Michael Dunne W. | Director | Purchase of securities on an exchange or from another person at price $ 1.40 per share. | 22 Dec 2023 | 25,000 | 113,754 (0%) | 0% | 1.4 | 35,000 | Ordinary Shares |
| Iterum Therapeutics Plc | W. Dunne Michael | Director | Purchase of securities on an exchange or from another person at price $ 1.84 per share. | 18 Dec 2023 | 10,000 | 88,754 (0%) | 0% | 1.8 | 18,442 | Ordinary Shares |
| Iterum Therapeutics Plc | Michael W. Dunne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2023 | 1,779 | 0 | - | - | Restricted Share Units | |
| Iterum Therapeutics Plc | Michael W. Dunne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2023 | 1,779 | 55,267 (0%) | 0% | - | Ordinary Shares | |
| Iterum Therapeutics Plc | Michael W. Dunne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 15,853 | 0 | - | - | Restricted Share Units | |
| Iterum Therapeutics Plc | Michael W. Dunne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 15,853 | 53,488 (0%) | 0% | 0 | Ordinary Shares | |
| Iterum Therapeutics Plc | Michael W. Dunne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2023 | 1,299 | 37,635 (0%) | 0% | 0 | Ordinary Shares | |
| Iterum Therapeutics Plc | Michael W. Dunne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2023 | 761 | 36,337 (0%) | 0% | - | Ordinary Shares | |
| Iterum Therapeutics Plc | Michael W. Dunne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2023 | 761 | 0 | - | - | Restricted Share Units | |
| Iterum Therapeutics Plc | Michael W. Dunne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2022 | 3,487 | 3,487 | - | - | Restricted Share Units | |
| Iterum Therapeutics Plc | Michael W. Dunne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2022 | 1,779 | 1,779 | - | - | Restricted Share Units | |
| Iterum Therapeutics Plc | Michael W. Dunne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2022 | 19,488 | 19,488 | - | - | Restricted Share Units | |
| Iterum Therapeutics Plc | Michael W. Dunne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2022 | 36,798 | 0 | - | - | Restricted Share Units | |
| Iterum Therapeutics Plc | Michael W. Dunne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2022 | 36,798 | 383,647 (2%) | 0% | - | Ordinary Shares | |
| Iterum Therapeutics Plc | Michael W. Dunne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 237,795 | 237,795 | - | - | Restricted Share Units | |
| Iterum Therapeutics Plc | Michael W. Dunne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2022 | 11,426 | 11,426 | - | - | Restricted Share Units | |
| Iterum Therapeutics Plc | Michael W. Dunne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Mar 2022 | 10,494 | 0 | - | - | Restricted Share Units | |
| Iterum Therapeutics Plc | Michael W. Dunne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Mar 2022 | 10,494 | 346,849 (2%) | 0% | 0 | Ordinary Shares | |
| Iterum Therapeutics Plc | Michael W. Dunne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2021 | 80,000 | 336,355 (2%) | 0% | 0 | Ordinary Shares | |
| Iterum Therapeutics Plc | Michael W. Dunne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 36,798 | 36,798 | - | - | Restricted Stock Units | |
| Iterum Therapeutics Plc | Michael W. Dunne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 10,494 | 10,494 | - | - | Restricted Stock Units | |
| Iterum Therapeutics Plc | Michael W. Dunne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2021 | 80,000 | 289,498 (1%) | 0% | 0 | Ordinary Shares | |
| Iterum Therapeutics Plc | Michael W. Dunne | Director | Sale of securities on an exchange or to another person at price $ 1.73 per share. | 25 Jan 2021 | 33,143 | 256,355 (1%) | 0% | 1.7 | 57,337 | Ordinary Shares |
| Iterum Therapeutics Plc | Michael W. Dunne | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 27 Oct 2020 | 61,540 | 209,498 (1%) | 0% | - | Ordinary Shares | |
| Iterum Therapeutics Plc | Michael W. Dunne | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 27 Oct 2020 | 46,155 | 46,155 | - | - | Warrants (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges